Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT07274657
Eligibility Criteria:
Inclusion Criteria:
* Patient, male or female, age ≥ 18 years old
* Patient with diagnosed pancreatic solid or mixed (cystic component ≤25 % of tumor volume) lesion
* Patient with adequate understanding of written and spoken French, able to sign written informed consent
* Patient affiliated with a social security system
Exclusion Criteria:
* Pregnant or breastfeeding woman
* Patient with usual contraindications to EUS- TA
* Patient with usual contraindications to SonoVue® administration
* Patient with a genetic syndrome associated pancreatic lesion (multiple neuroendocrine neoplasia type 1 (MEN1), type 1 neurofibromatosis (NF), Von-Hippel Lindau (VHL) disease)
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
* Patient unable to perform the monitoring
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07274657
Study Brief:
Protocol Section:
NCT07274657